0000000000210434

AUTHOR

Rossi A.

showing 5 related works from this author

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STE…

2011

Introduction: Treatment of elderly patients with small cell lung cancer (SCLC) is based on scanty evidence. Methods: Patients with extensive SCLC, age >70 years, and performance status 0-2 were eligible for a study looking for optimal two-drug combination of gemcitabine (Gem) with vinorelbine (Vin), etoposide (Eto), cisplatin (Cis), or carboplatin (Car). Gemcitabine dose was the same (1000 mg/m2, days 1-8) in all combinations. A two-stage minimax flexible design for response was applied to GemVin combination (Vin 25 mg/m2, days 1-8). For GemCar, GemCis, GemEto, a phase I-II Bayesian design was applied, looking for the optimal dose of the partner drugs. Objective response rate ≥60% and un…

OncologyMaleLung NeoplasmsDeoxycytidineCarboplatinchemistry.chemical_compoundElderlyAntineoplastic Combined Chemotherapy Protocols80 and overCarcinoma Small CellMultivariate AnalysiEtoposideEtoposidePlatinum compoundsAged 80 and overArea under the curveSCLCVinorelbinePrognosisElderly; Etoposide; Gemcitabine; Platinum compounds; SCLC; Vinorelbine; Aged; Aged 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma Small Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Multivariate Analysis; Prognosis; Proportional Hazards Models; Quality of Life; Treatment Outcome; Vinblastine; VinorelbineTreatment OutcomeOncologyPlatinum compoundToxicityFemalemedicine.drugHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyPrognosiVinorelbineVinblastineDisease-Free SurvivalInternal medicinemedicineHumansAgedProportional Hazards ModelsCisplatinAntineoplastic Combined Chemotherapy ProtocolPerformance statusbusiness.industryCarcinomaSmall CellGemcitabineGemcitabineCarboplatinSurgeryLung NeoplasmchemistryMultivariate AnalysisProportional Hazards ModelQuality of LifeCisplatinbusiness
researchProduct

Search for di-muon decays of a low-mass Higgs boson in radiative decays of the Gamma(1S)

2013

We search for di-muon decays of a low-mass Higgs boson (A(0)) produced in radiative Gamma(1S) decays. The Gamma(1S) sample is selected by tagging the pion pair in the Gamma(2S, 3S) -> pi(+)pi(-) Gamma(1S) transitions, using a data sample of 92.8 x 10(6) Gamma(2S) and 116.8 x 10(6) Gamma(3S) events collected by the BABAR detector. We find no evidence for A(0) production and set 90% confidence level upper limits on the product branching fraction B(Gamma(1S) -> gamma Lambda(0)) x B(Lambda(0)->mu(+)mu(-)) in the range of (0.28 - 9.7) x 10(-6) for 0.212 gamma Lambda(0), Lambda(0) -> mu(+)mu(-) to set limits on the effective coupling of the b quark to the Lambda(0).

Nuclear and High Energy PhysicsParticle physicsElectron–positron annihilationAstrophysics::High Energy Astrophysical PhenomenaQuarkonium01 natural sciencesBottom quarkHigh Energy Physics - ExperimentNuclear physicsPion0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010306 general physicsPhysicsMuon010308 nuclear & particles physicsBranching fractionHigh Energy Physics::PhenomenologyBABAR detectorQuarkoniumHEP3. Good healthPACS: 12.60.Fr 12.60.Jv 13.20.Gd 13.35.BvBaBarHiggs bosonLeptonic decaysFísica nuclearHigh Energy Physics::ExperimentMinimal Supersymmetric Standard Model
researchProduct

Multi-objective Optimization of Energy Hubs at the Crossroad of Three Energy Distribution Networks

2016

This paper provides a multi-objective optimization framework aimed at the management of a multi-carrier energy system involving both electricity and hydrogen. Using the concept of the multi-carrier hub, the proposed system has been modelled in order to define completely every energy flow inside the plant. After that, a heuristic multi-objective optimization algorithm, the Non-dominated Sorting Genetic Algorithm II, has been implemented for the energy management of the plant, taking into account simultaneously three different objective functions related to economic and technical goals. This optimization process provides the set point defining the working configuration of the plant for a dayl…

Settore ING-IND/33 - Sistemi Elettrici Per L'EnergiaOPC protocolmulti-objective optimizationenergy management systemmulti-carrier hubhydrogen storage
researchProduct

Death in hospital following ICU discharge: insights from the LUNG SAFE study

2021

Abstract Background To determine the frequency of, and factors associated with, death in hospital following ICU discharge to the ward. Methods The Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE study was an international, multicenter, prospective cohort study of patients with severe respiratory failure, conducted across 459 ICUs from 50 countries globally. This study aimed to understand the frequency and factors associated with death in hospital in patients who survived their ICU stay. We examined outcomes in the subpopulation discharged with no limitations of life sustaining treatments (‘treatment limitations’), and the subpopulations with tre…

MaleARDSLUNG SAFEhealth care facilities manpower and servicesAcute hypoxemic respiratory failure; Acute respiratory distress syndrome; Hospital survival; ICU discharge; LUNG SAFEKaplan-Meier EstimateCritical Care and Intensive Care MedicineAcute hypoxemic respiratory failure; Acute respiratory distress syndrome; Hospital survival; ICU discharge; LUNG SAFE;0302 clinical medicineRisk Factors030212 general & internal medicineProspective StudiesProspective cohort studyAcute hypoxemic respiratory failureCOPDAcute respiratory distress syndromeICU dischargeMedical emergencies. Critical care. Intensive care. First aidMiddle AgedPatient DischargeLUNG SAFE.Intensive Care Unitsmedicine.anatomical_structureLung safeSOFA scoreFemaleRespiratory InsufficiencyAdultmedicine.medical_specialtyNOHospital survival03 medical and health sciencesSettore MED/41 - ANESTESIOLOGIAmedicineHumansddc:610Risk factorMortalityAgedLungRC86-88.9business.industryResearch030208 emergency & critical care medicinemedicine.diseaseLogistic Modelslnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]Respiratory failureEmergency medicineObservational studybusiness
researchProduct

Linee Guida per la Sedazione in Endoscopia Digestiva

2006

researchProduct